NATIONAL HEALTH INVESTORS INC NHI on NYSE
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0000877860
0000877860
EIN:
62-1470956
62-1470956
LEI:
(CF Office: 05 Real Estate & Construction)
Business address:
222 ROBERT ROSE DRIVE, MURFREESBORO, TN, 37129
Phone: 6158909100
222 ROBERT ROSE DRIVE, MURFREESBORO, TN, 37129
Phone: 6158909100
Mailing address:
222 ROBERT ROSE DRIVE, MURFREESBORO, TN, 37129
222 ROBERT ROSE DRIVE, MURFREESBORO, TN, 37129
Category:
Large accelerated filer
Large accelerated filer
Filings:
1,431 EDGAR filings since February 1, 1994
1,431 EDGAR filings since February 1, 1994
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 28, 2025 - PREC14A: Preliminary proxy statements, contested solicitations Open documentClick to Open document FilingOpen filingClick to Open filing
- March 27, 2025 - DEFA14A: Additional definitive proxy soliciting materials and Rule 14(a)(12) material Open documentClick to Open document FilingOpen filingClick to Open filing
- March 27, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 9.01 - Financial Statements and Exhibits
- March 24, 2025 - PREC14A: Preliminary proxy statements, contested solicitations Open documentClick to Open document FilingOpen filingClick to Open filing
- February 25, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
Selected Filings
[+] 8-K (current reports)
- March 27, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 9.01 - Financial Statements and Exhibits
- February 25, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- February 25, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- February 25, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- February 10, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 7.01 - Regulation FD Disclosure
- January 8, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- January 8, 2025 - 8-K/A: Current report - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- February 25, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 5, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 6, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 6, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- March 28, 2025 - PREC14A: Preliminary proxy statements, contested solicitations Open documentClick to Open document FilingOpen filingClick to Open filing
- March 24, 2025 - PREC14A: Preliminary proxy statements, contested solicitations Open documentClick to Open document FilingOpen filingClick to Open filing
- April 4, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 5, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 5, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 5, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
No beneficial ownership filings for this company in last 365 days
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 25 of 1,004 entries
Data source:
CIK0000877860.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
